Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Hilton Grand Vacations
HGV
$3.66B
| $5.31M | ﹤0.01% |
271,814
+86,363
| +47% | +$1.7M |
|
2727
Coeur Mining
CDE
$16.4B
| $5.31M | ﹤0.01% |
1,045,953
-1,226,016
| -54% | -$5.58M |
|
2728
CALL
iShares Biotechnology ETF
IBB
$9.48B
| $5.3M | ﹤0.01% |
38,800
+17,000
| +78% | +$2.17M |
|
2729
PUT
RH
RH
$3.54B
| $5.3M | ﹤0.01% |
21,300
-50,000
| -70% | -$9.06M |
|
2730
BioXcel Therapeutics
BTAI
$25.2M
| $5.3M | ﹤0.01% |
6,249
+3,130
| +100% | +$2.04M |
|
2731
CALL
KKR & Co
KKR
$91.9B
| $5.28M | ﹤0.01% |
170,900
-29,100
| -15% | -$782K |
|
|
VNTR
2732
DELISTED
Venator Materials PLC
VNTR
| $5.28M | ﹤0.01% |
2,948,126
-1,580,577
| -35% | -$2.46M |
|
2733
DHT Holdings
DHT
$2.95B
| $5.27M | ﹤0.01% |
1,027,076
-1,719,192
| -63% | -$11M |
|
|
IRBT
2734
DELISTED
iRobot
IRBT
| $5.25M | ﹤0.01% |
62,603
-532,393
| -89% | -$35.1M |
|
2735
3D Systems Corp
DDD
$601M
| $5.24M | ﹤0.01% |
750,057
-13,900
| -2% | -$104K |
|
2736
Harmony Gold Mining
HMY
$11.3B
| $5.24M | ﹤0.01% |
1,255,939
+1,133,639
| +927% | +$3.73M |
|
2737
Cushman & Wakefield Ltd
CWK
$3.24B
| $5.23M | ﹤0.01% |
419,782
+119,733
| +40% | +$1.35M |
|
2738
Tactile Systems Technology
TCMD
$651M
| $5.2M | ﹤0.01% |
125,576
+4,732
| +4% | +$222K |
|
|
AIMT
2739
DELISTED
Aimmune Therapeutics
AIMT
| $5.2M | ﹤0.01% |
311,369
-134,799
| -30% | -$2.29M |
|
2740
Arcutis Biotherapeutics
ARQT
$3.35B
| $5.2M | ﹤0.01% |
171,914
-27,716
| -14% | -$801K |
|
2741
Kontoor Brands
KTB
$4.41B
| $5.2M | ﹤0.01% |
291,821
-79,080
| -21% | -$1.41M |
|
2742
OneSpaWorld
OSW
$2.68B
| $5.19M | ﹤0.01% |
1,088,653
+5,811
| +0.5% | +$31.5K |
|
|
DEA
2743
Easterly Government Properties
DEA
$1.18B
| $5.17M | ﹤0.01% |
89,384
-133,110
| -60% | -$8.45M |
|
|
RDS.A
2744
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.17M | ﹤0.01% |
158,000
-107,200
| -40% | -$3.68M |
|
2745
Kulicke & Soffa
KLIC
$4.71B
| $5.16M | ﹤0.01% |
247,912
+28,748
| +13% | +$651K |
|
2746
CALL
Kraft Heinz
KHC
$29.7B
| $5.16M | ﹤0.01% |
161,800
-35,100
| -18% | -$1.05M |
|
2747
Movado Group
MOV
$837M
| $5.16M | ﹤0.01% |
475,814
-72,464
| -13% | -$782K |
|
|
SVC
2748
Service Properties Trust
SVC
$1.07B
| $5.16M | ﹤0.01% |
145,468
+23,746
| +20% | +$827K |
|
2749
Matthews International
MATW
$850M
| $5.15M | ﹤0.01% |
269,482
+12,241
| +5% | +$261K |
|
|
TBIO
2750
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $5.14M | ﹤0.01% |
287,015
+232,984
| +431% | +$3.51M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.